Today: 28 June 2026
Browse Category

Stock Market 23 January 2026

Plug Power stock price today: PLUG steadies near $2.60 as share-vote clock ticks and Galp project update lands

Plug Power stock price today: PLUG steadies near $2.60 as share-vote clock ticks and Galp project update lands

Plug Power shares fell 0.2% to $2.59 Friday after a 16.7% surge Thursday. Investors await a Jan. 29 shareholder vote on doubling authorized shares to 3 billion, a move CEO Andy Marsh says is needed to avoid a reverse stock split. Plug and Walmart canceled a 2017 warrant for over 55 million shares, replacing it with a technology licensing deal. Plug completed installation of 100 MW electrolyzers at Galp’s Sines refinery in Portugal.
Johnson & Johnson stock today: Why JNJ can’t break out as talc risk shadows upbeat 2026 outlook

Johnson & Johnson stock today: Why JNJ can’t break out as talc risk shadows upbeat 2026 outlook

Johnson & Johnson shares traded nearly flat at $218.59 by late Friday morning as Wall Street upgrades met renewed worries over federal talc lawsuits. A special master recommended allowing plaintiffs’ experts to testify that J&J talc products can cause ovarian cancer, affecting over 67,500 cases. The company reported Q4 sales up 9.1% to $24.6 billion and projected 2026 sales of up to $101 billion.
Enphase Energy (ENPH) stock holds near $40 after Citi and Goldman upgrades — what to watch into earnings

Enphase Energy (ENPH) stock holds near $40 after Citi and Goldman upgrades — what to watch into earnings

Enphase shares edged up less than 0.1% to $40.50 early Friday after jumping 12.54% Thursday on heavy volume. Citi and Goldman Sachs upgraded the stock, citing limited downside and strong Q4 demand tied to tax credit deadlines. Investors are watching early-February results for signs of sustained demand. Enphase remains 43% below its 52-week high.
Why Procter & Gamble stock is edging up today after earnings and new analyst upgrades

Why Procter & Gamble stock is edging up today after earnings and new analyst upgrades

Procter & Gamble shares rose 0.2% to $150.28 in late morning trading Friday after a 2.7% jump Thursday. Quarterly net sales missed estimates at $22.21 billion, with U.S. volumes down 1%, but adjusted earnings beat forecasts. JPMorgan and Wells Fargo raised price targets, citing focus on U.S. volumes and upcoming policy guidance. The company cut its fiscal 2026 diluted earnings growth forecast to 1%–6%.
Walmart stock ticks higher as PhonePe IPO share-sale details emerge — what’s next for WMT

Walmart stock ticks higher as PhonePe IPO share-sale details emerge — what’s next for WMT

Walmart shares rose 0.3% to $118.20 Friday after Reuters reported the company will sell about 46 million PhonePe shares in the Indian payments unit’s IPO. The offering, expected to cut Walmart’s stake by roughly 12%, is entirely secondary, with proceeds going to selling shareholders. CEO transition is set for Feb. 1, and quarterly earnings are due Feb. 19.
23 January 2026
Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings

Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings

Thermo Fisher Scientific shares fell 1.2% to $631.70 in late morning trading Friday, ending a two-day rally as investors awaited the company’s Jan. 29 earnings report. Peers Danaher and Agilent also declined. Traders are watching for management’s outlook on demand and margins. A recent minor debt security filing drew some attention but did not involve common stock.
Palantir stock price rises as retail ETF spotlight lands ahead of Fed week and earnings

Palantir stock price rises as retail ETF spotlight lands ahead of Fed week and earnings

Palantir shares rose 1.7% to $168.79 Friday, reaching a high of $169.20 on volume of 8.6 million. The stock gained after being added to the new Defiance Retail Kings ETF and receiving a buy rating from Phillip Securities. Palantir recently signed a major contract with South Korea’s HD Hyundai. The company will report fourth-quarter results after U.S. markets close on Feb. 2.
Google stock price today: Alphabet GOOG Class C ticks up as judge keeps search antitrust suit alive

Google stock price today: Alphabet GOOG Class C ticks up as judge keeps search antitrust suit alive

Alphabet’s Class C shares (GOOG) rose 0.5% to $332.35 after a U.S. judge allowed a consumer antitrust lawsuit over Google’s search dominance to proceed. The stock’s market cap neared $2.94 trillion, trading between $329.68 and $333.97. Analyst Josh Beck raised his price target to $400, citing AI momentum. The lawsuit challenges Google’s default search engine deals with device makers.
23 January 2026
Netflix stock price rises as CEO slams Paramount’s Warner bid, Senate hearing nears

Netflix stock price rises as CEO slams Paramount’s Warner bid, Senate hearing nears

Netflix shares rose 2% to $85.21 Friday as investors tracked its $82.7 billion cash bid for Warner’s studio and streaming assets. Paramount extended its $108 billion Warner tender offer deadline to Feb. 20 after only 6.8% of shares were tendered. Netflix co-CEO Ted Sarandos will testify before a Senate committee in February. Warner’s board has approved Netflix’s $27.75-a-share cash offer.
Broadcom stock slides in regular trade as chip jitters return; AVGO eyes Fed week

Broadcom stock slides in regular trade as chip jitters return; AVGO eyes Fed week

Broadcom shares fell 2.7% to $316.78 Friday morning after a U.S. government contract put its VMware unit in focus. Chip stocks dropped as traders weighed earnings forecasts ahead of next week’s Federal Reserve meeting. Intel slid 14.9% on a weak outlook, pulling the Philadelphia Semiconductor Index down 1.6%. The federal “OneGov” deal offers agencies up to 64% off VMware software through May 2027.
GE Aerospace stock steadies after brutal post-earnings slide — what investors are watching now

GE Aerospace stock steadies after brutal post-earnings slide — what investors are watching now

GE Aerospace shares rose 0.5% to $296.40 Friday morning, recovering slightly after a 7.4% drop Thursday following earnings and a 2026 outlook that missed expectations. The company reported fourth-quarter orders up 74% to $27 billion and projected 2026 adjusted profit per share of $7.10–$7.40. Airlines raised concerns about rising engine maintenance costs and longer repair delays amid ongoing aircraft shortages.
AMD stock rises again: Advanced Micro Devices extends rally as traders eye earnings and AI-server demand

AMD stock rises again: Advanced Micro Devices extends rally as traders eye earnings and AI-server demand

AMD shares rose 3.6% to $262.86 in early New York trading Friday, heading for a ninth straight gain and the longest winning streak in nearly six years. The rally comes ahead of AMD’s Feb. 3 earnings report, with investors focused on demand for server processors and data center AI. Intel shares fell after a weak forecast. AMD touched $266.76 before paring gains.
Intel stock plunges 16% on weak outlook, weighing on Dow and S&P 500

Intel stock plunges 16% on weak outlook, weighing on Dow and S&P 500

Intel shares plunged 15.7% to $45.79 Friday after the company warned supply chain issues would hit near-term results, despite beating fourth-quarter expectations. The drop erased over $35 billion in market value and pressured broader U.S. markets at the open. Intel forecast first-quarter revenue of $11.7–$12.7 billion, with supply expected to bottom out before improving later in the year.
23 January 2026
Dow Jones today: Index slides as Goldman, AmEx drag; Intel slump sets up Fed week

Dow Jones today: Index slides as Goldman, AmEx drag; Intel slump sets up Fed week

The Dow Jones Industrial Average fell 0.52% by mid-morning Friday, down 256 points to 49,127.78, as Intel shares plunged 14% on weak forecasts and supply issues. Goldman Sachs dropped 2.8% and American Express lost 1.8%, together shaving about 204 points from the index. Oil prices rebounded after President Trump referenced an “armada” moving toward Iran. Investors await next week’s Federal Reserve meeting.

Stock Market Today

  • Neurocrine Biosciences (NBIX) Posts Positive Phase 3 Data, Highlighting Growth Potential
    June 28, 2026, 2:29 AM EDT. Neurocrine Biosciences Inc. (NASDAQ:NBIX) showcased promising two-year Phase 3 results for CRENESSITY (crinecerfont) at ENDO 2026. The drug improves growth outcomes in children with classic congenital adrenal hyperplasia by slowing advanced bone age progression and enhancing predicted adult height. This is attributed to controlled androgen levels and reduced glucocorticoid exposure, the steroids commonly used in treatment. Caregivers reported high satisfaction and optimism about long-term health impacts. CRENESSITY was well-tolerated, with no new safety concerns, and showed benefits extending to cardiometabolic health. Neurocrine focuses on neuroscience-related pharmaceuticals and represents a notable high-growth NASDAQ stock, though some investors might favor AI stocks with potentially higher upside and lower risk.

Latest articles

Hecla Mining (NYSE:HL) sees stock rebound, volume jumps as silver prices in focus

Hecla Mining (NYSE:HL) sees stock rebound, volume jumps as silver prices in focus

28 June 2026
Hecla Mining surged 5.3 times its average trading volume Friday as index rebalancing drove 112.44 million shares traded, but the stock’s 2.6% weekly drop still beat silver and peer ETFs, signaling company-specific strength; investors now watch if Hecla can hold above $15.54 without rebalancing flows as macro risks loom.
Go toTop